Novo Nordisk advances obesity candidate to late-stage program after weight loss of less than 12% US$ 23.78 Min. order: 1 piece ★★★★★ 4.8 (121 reviews) Sold : Login>>
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity US$ 20.11 Min. order: 1 piece ★★★★★ 4.5 (265 reviews) Sold : Login>>
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug US$ 28.21 Min. order: 1 piece ★★★★★ 4.7 (27 reviews) Sold : Login>>
CagriSema vs Tirzepatide: 23% Weight Loss in Phase 3 Trial US$ 28.84 Min. order: 1 piece ★★★★★ 4.6 (159 reviews) Sold : Login>>
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product' – NBC Connecticut US$ 20.10 Min. order: 1 piece ★★★★★ 4.6 (56 reviews) Sold : Login>>